Thelansis

Dry Eye Disease (DED) Market Outlook Thelansis’s “Dry Eye Disease (DED) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Dry Eye Disease (DED) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? ...

Dry Eye Disease (DED) Market Outlook Thelansis’s “Dry Eye Disease (DED) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Dry Eye Disease (DED) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Dry Eye Disease (DED) Overview Dry eye disease (DED), also referred to as keratoconjunctivitis sicca, is a prevalent and persistent condition affecting the ocular surface. It is characterized by an inability to produce an adequate quantity or quality of tears to moisturize the eyes. Several common risk factors contribute to this syndrome, including aging, being female, exposure to low-humidity environments, using certain systemic medication...

 Dry eye disease (DED), also referred to as keratoconjunctivitis sicca, is a prevalent and persistent condition affecting the ocular surface. It is characterized by an inability to produce an adequate quantity or quality of tears to moisturize the eyes. Several common risk factors contribute to this syndrome, including aging, being female, exposure to low-humidity environments, using certain systemic medications, and autoimmune disorders. DED is categorized into two main types: "dry eye with reduced tear production," referred to as aqueous deficient, and "dry eye with increased tear film evaporation," known as the hyper-evaporative type. Among those affected, about 10% suffer from aqueous deficient DED, while more than 80% experience the hyper-evaporative type, often related to meibomian gland dysfunction (MGD) or a combination of both. The consequences of DED can be substantial, significantly impacting one's vision and overall quality of life. The associated sy...